Dr. Tania Jain, MBBS is a physician-scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel, Comprehensive Cancer Center at Johns Hopkins. Her focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. Her primary research focus is to develop strategies to prevent the relapse of hematological malignancies following allogeneic stem cell transplantation. Additionally, She serves as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies.
Tania Jain's academic interest in this space lies in studying the aspects of the toxicity of CAR T cell therapy with an aim to improve long-term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are her area of interest, and she works to study newer drugs in an early phase of development and also its treatment using allogeneic stem cell transplantation.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)